carbapenemaseproduc
enterobacteriacea
steadili
spread
worldwid
last
decad
nine
patient
identifi
prospect
follow
hospit
cours
identifi
epidemiolog
clinic
profil
outcom
patient
one
cultur
posit
cre
isol
contribut
total
eleven
posit
cultur
variou
site
without
includ
duplic
isol
obtain
site
isol
patient
includ
five
klebseilla
pneumonia
three
escherichia
coli
one
enterobact
aerogen
five
isol
grown
blood
cultur
three
wound
cultur
one
urin
cultur
one
respiratori
cultur
one
abscess
collect
five
surviv
hospit
cours
five
patient
die
due
sever
sepsi
septic
shock
multiorgan
failur
nine
isol
cre
identifi
molecular
analysi
avail
four
k
pneumonia
confirm
blandm
one
purpos
control
spread
cre
institut
recommend
consid
activ
surveil
cultur
screen
patient
transfer
hospit
come
highli
endem
set
admiss
organ
carbapenemaseproduc
enterobacteriacea
cre
includ
nonferment
caus
major
public
health
concern
world
intern
travel
migrat
contamin
food
product
respons
spread
microorgan
sever
countri
beyond
origin
extens
use
carbapenem
hospit
set
particularli
infect
control
practic
inadequ
contribut
increas
preval
carbapenem
resist
enterobacteriacea
cre
spread
infect
mediat
potenti
organ
widespread
transmiss
via
mobil
genet
element
spread
escherichia
coli
acquir
plasmidborn
carbapenemas
report
carbapenemaseproduc
gramneg
caus
seriou
nosocomi
infect
particularli
critic
ill
patient
associ
increas
mortal
rate
rang
bacteremia
sometim
outbreak
addit
spread
cre
commun
major
concern
usual
demonstr
resist
commonli
use
antibiot
quinolon
aminoglycosid
recent
panresist
antimicrobi
agent
includ
colistin
tigecyclin
also
report
limit
therapeut
option
avail
treat
patient
infect
cre
made
organ
epidemiolog
diagnost
import
date
clear
data
effect
therapi
infect
caus
cre
avail
combin
treatment
two
antibiot
shown
effect
monotherapi
infect
caus
cre
activ
surveil
detect
colon
patient
implement
strict
infect
control
measur
contact
precaut
import
way
prevent
introduct
transmiss
bacteria
healthcar
set
increas
preval
cre
isol
includ
cre
outbreak
hospit
grow
problem
saudi
arabia
main
purpos
case
seri
evalu
describ
import
clinic
epidemiolog
featur
cre
infect
institut
prospect
chart
review
conduct
use
hospit
king
khalid
univers
hospit
laboratori
patient
inform
computer
data
document
made
physician
period
octob
octob
hospit
epidemiolog
databas
use
identifi
admit
patient
blood
respiratori
urin
wound
cultur
posit
cre
inclus
criteria
includ
age
year
older
sign
symptom
infect
patient
colon
without
evid
infect
exclud
implic
cre
colon
true
infect
unclear
patient
studi
enterobacteriacea
isol
defin
carbapenem
nonsuscept
mic
gml
base
clsi
guidelin
identif
isol
well
antibiot
suscept
test
carri
autom
system
vitek
marci
letoil
franc
test
antibiot
includ
extendedspectrum
cephalosporin
ceftriaxon
ceftazidim
cefepim
carbapenem
ertapenem
imipenem
meropenem
aminoglycosid
amikacin
gentamicin
quinolon
ciprofloxacin
tigecyclin
colistin
nondupl
carbapenemnonsuscept
isol
resist
thirdgener
cephalosporin
select
investig
modifi
hodg
test
mht
mbl
etest
perform
confirmatori
test
select
isol
four
nine
carbapenemnonsuscept
isol
kit
avail
pcr
test
use
primer
target
blaimp
blavim
blage
blakpc
nine
patient
infect
cre
organ
identifi
patient
one
cultur
posit
cre
isol
hospit
cours
contribut
total
eleven
posit
cultur
variou
site
without
count
duplic
isol
obtain
site
isol
patient
includ
five
klebseilla
pneumonia
three
e
coli
one
enterobact
aerogen
five
isol
obtain
blood
cultur
three
wound
cultur
one
urin
cultur
one
respiratori
cultur
one
abscess
collect
nine
isol
cre
identifi
three
k
pneumonia
confirm
molecular
analysi
one
k
pneumonia
isol
blood
identifi
molecular
analysi
avail
five
isol
tabl
summar
key
comorbid
condit
isol
treatment
outcom
full
suscept
profil
determin
clinic
laboratori
standard
institut
clsi
e
test
method
shown
tabl
comorbid
condit
diabet
mellitu
malign
chronic
kidney
diseas
cathet
placement
surgic
procedur
prior
hospit
within
day
identifi
among
patient
five
patient
diabet
mellitu
three
patient
renal
insuffici
two
histori
malign
five
ischem
heart
diseasehypertens
rheumat
heart
diseas
one
renal
transplant
six
patient
either
prior
icu
admiss
spent
time
intens
care
hospit
cours
tabl
clinic
characterist
laboratori
find
nine
cre
infect
patient
case
five
patient
die
due
sever
sepsi
septic
shock
multiorgan
failur
six
patient
hospit
within
day
transfer
hospit
prior
current
admiss
receiv
antibiot
previous
four
patient
surgic
procedur
within
day
onset
infect
infecti
diseas
physician
consult
treatment
recommend
nine
case
present
seri
except
one
isol
colistin
resist
gml
cre
isol
identifi
nine
patient
suscept
colistin
show
variabl
suscept
aminoglycosid
mic
rang
gml
fluoroquinolon
mic
rang
gml
carbapenemas
produc
highli
resist
third
fourth
gener
cephalosporin
includ
piperacillintazobactam
mic
rang
gml
tigecyclin
antimicrobi
agent
activ
isol
mic
gml
prior
treatment
carbapenem
document
three
patient
four
patient
given
aminoglycosid
three
given
colistin
none
given
fluoroquinolon
six
patient
receiv
combin
treatment
includ
carbapenem
two
patient
receiv
tigecyclin
one
septicemia
ventil
associ
pneumonia
caus
k
pneumonia
die
psoa
abscess
caus
e
coli
discharg
interestingli
one
patient
histori
surgeri
hip
fractur
india
month
prior
present
anoth
patient
transfer
egypt
carbapenemas
gene
detect
clinic
isol
year
old
male
najran
south
region
saudi
arabia
known
hypertens
ischem
heart
diseas
benign
prostat
hyperplasia
partial
resect
year
ago
long
stand
rheumatoid
arthriti
treat
steroid
multipl
admiss
due
urinari
tract
infect
urinari
retent
urosepsi
present
emerg
two
month
prior
admiss
upper
gastro
intestin
bleed
melena
foley
cathet
put
urinari
obstruct
associ
hematuria
gener
joint
pain
post
prostatectomi
urin
cultur
show
candida
albican
treat
fluconazol
day
repeat
urin
cultur
show
high
wbc
bacteria
treat
ciprofloxacin
admit
elect
endoscopi
evalu
physic
well
afebril
c
bp
mm
hg
lab
investig
show
low
hemoglobin
hypocalcemia
day
urin
cultur
show
cfuml
klebsiella
pneumonia
resist
antibiot
includ
carbapenem
sensit
colistin
patient
start
empir
ceftriaxon
g
iv
daili
imipenem
mg
iv
hour
day
also
receiv
two
dose
gentamicin
discharg
home
repeat
urin
cultur
show
neg
result
year
old
male
came
emerg
room
may
septic
shock
present
highgrad
fever
low
blood
pressur
known
advanc
bladder
cancer
stage
iv
metastasi
requir
surgeri
chemotherapi
radiotherapi
also
diabet
mellitu
ischem
heart
diseas
bilater
deep
vein
thrombosi
dvt
medic
previou
record
reveal
multipl
admiss
due
urinari
tract
infect
posit
blood
cultur
grew
e
coli
esbl
produc
treat
meropenem
g
iv
q
h
day
patient
discharg
complet
month
intens
care
icu
blood
cultur
show
neg
result
two
week
later
current
admiss
came
back
emerg
room
sever
sepsi
septic
shock
uti
blood
pressur
low
lower
limb
swell
high
wbc
low
hemoglobin
receiv
one
unit
pack
blood
blood
urin
cultur
show
e
coli
cfuml
esbl
carbapenemas
produc
patient
admit
icu
start
gentamicin
meropenem
day
also
receiv
one
dose
ceftriaxon
clinic
condit
continu
deterior
episod
confus
loss
conscious
due
sever
sepsi
manag
aggress
icu
given
mani
regimen
antimicrobi
agent
continu
deterior
die
august
blood
urin
cultur
posit
e
coli
esbl
carbapenemas
produc
sensit
colistin
amikacin
tigecyclin
year
old
woman
transfer
intens
care
unit
privat
hospit
novemb
septic
shock
diabet
mellitu
chronic
kidney
diseas
dialysi
rheumat
heart
diseas
sever
mitral
aortic
stenosi
patient
present
two
month
ago
privat
hospit
short
breath
repeat
cardiac
arrest
intub
stay
icu
two
month
develop
bedsor
back
larg
abscess
requir
incis
drainag
hospit
ventilatorassoci
pneumonia
due
stenotrophomona
multophilia
blood
stream
infect
multidrug
resist
acinetobact
spp
receiv
multipl
antibiot
includ
vancomycin
linezolid
imepenem
tigecyclin
ceftazidim
referr
hospit
icu
care
patient
sedat
hemodynam
unstabl
low
level
conscious
sign
septic
shock
hypotens
mm
hg
hypothermia
c
bradycardia
beatsmin
patient
intub
oxygen
requir
pressur
support
low
dose
vasopressor
dose
dopamin
noradrenalin
hydrocortison
insulin
infus
central
venou
cathet
nasogastr
tube
folli
cathet
pupil
dilat
mm
sluggish
reaction
light
examin
back
show
big
cm
infrascapular
abscess
chest
examin
reveal
bilater
basal
crepit
lab
investig
show
hemoglobin
wbc
cellsmm
platelet
na
k
inr
urea
creatinin
albumin
start
empir
colistin
iv
meropenem
igm
iv
vancomycin
mg
iv
od
amikacin
mg
ivod
two
day
admiss
caspofungin
mg
od
given
transesophag
echocardiogram
tee
done
exclud
infect
endocard
rule
veget
seen
next
day
stabl
vancomycin
suspend
two
week
admiss
septic
work
two
consecut
blood
cultur
central
line
dialysi
line
show
blood
stream
infect
k
pneumonia
resist
antibiot
includ
carbapenem
except
colistin
isol
grown
tracheal
aspir
isol
shown
newdelhi
metallobetalactamas
produc
ndm
accordingli
start
colistin
tigecyclin
central
line
chang
repeat
blood
cultur
neg
next
two
day
patient
show
mild
improv
clinic
condit
two
week
treatment
develop
breakthrough
fever
septic
workup
done
candida
glabrata
multidrug
resist
pseudomona
aeroginosa
isol
blood
tigecyclin
discontinu
line
chang
repeat
echocardiogram
ultrasound
abdomen
done
ophthalmolog
team
consult
suspect
dissemin
candidemia
patient
clinic
improv
becam
afebril
hospit
stay
develop
persist
wateri
diarrhea
colonoscopi
clostridium
difficil
toxin
antigen
detect
test
neg
repeat
blood
cultur
grew
carpapenem
resist
k
pneumonia
cre
resist
antimicrobi
agent
includ
colistin
patient
develop
hyperkalemia
sever
metabol
acidosi
deterior
renal
function
acut
adult
respiratori
distress
syndrom
ard
blood
pressur
drop
mm
hg
multiorgan
failur
due
refractori
septic
shock
arrest
die
month
hospit
laboratori
test
reveal
meropenem
imipenem
mic
gml
determin
etest
isol
confirm
carbapenemas
produc
modifi
hodg
test
clsi
pcr
sequenc
confirm
presenc
plasmid
analysi
reveal
carri
kb
geneexpert
analysi
use
xbai
carri
two
k
pneumonia
isol
patient
carbapenemresist
k
pneumonia
blood
tracheal
aspir
year
old
bed
ridden
male
known
diabet
mellitu
hypertens
old
ischem
stroke
infect
bedsor
present
emerg
room
cardiac
arrest
decemb
cardiopulmonari
resuscit
cpr
start
immedi
high
flow
inotrop
antibiot
blood
volum
monitor
diagnos
urinari
tract
infect
uti
privat
clinic
one
week
prior
present
histori
surgeri
hip
fractur
india
month
ago
patient
hemodynam
unstabl
afebril
high
dose
vasopressor
noradrenalin
ivi
mcgmin
lab
investig
show
wbc
cellsmm
hb
lactic
acid
creatinin
ph
coagul
profil
show
pictur
dissemin
intravascular
coagul
dic
explain
high
ptt
low
platelet
count
low
fibrinogen
secondari
septicemia
given
unit
prbc
vitamin
k
stat
dose
start
empir
vancomycin
tazocin
icu
stay
develop
deep
vein
thrombosi
dvt
acut
lower
limb
ischemia
bluish
discolor
swell
gangren
bilater
iatrogen
emphysema
heparin
start
patient
condit
complic
acut
renal
failur
dic
septic
shock
due
aspir
pneumonia
uti
arrest
die
second
day
admiss
due
multipl
comorbid
two
day
death
blood
cultur
grew
e
coli
esbl
produc
multidrugresist
carbapenem
resist
tracheal
aspir
cultur
grew
heavi
growth
k
pneumonia
resist
antibiot
except
carbapenem
colistin
moder
growth
multiresist
acinetobact
baumannii
wound
cultur
deep
infect
bedsor
also
show
heavi
growth
e
coli
esbl
produc
carbapenem
resist
growth
pseudomona
aeruginosa
alcohol
male
transfer
intens
care
unit
privat
hospit
egypt
octob
state
confus
disturb
consciou
level
diffus
abdomin
pain
diagnos
acut
pancreat
multipl
organ
failur
present
sever
sepsi
secondari
communityacquir
pneumonia
cap
pancreat
admit
intens
care
unit
icu
acut
respiratori
distress
syndrom
ard
intub
septic
shock
requir
inotrop
transfer
patient
one
attack
gener
tonicclon
seizur
immedi
start
keppra
mg
bid
patient
sedat
hemodynam
unstabl
unconsci
coma
scale
bp
mm
hg
hyperthermia
c
tachycardia
beatsmin
laboratori
investig
show
hemoglobin
gl
wbc
platelet
albumin
gl
creatinin
mcmoll
troponini
mcgl
start
empir
tazocin
stay
icu
spike
high
temperatur
c
blood
cultur
grew
gram
neg
bacilli
identifi
k
pneumonia
crkp
mdro
resist
tazocin
imipenem
ciprofloxacin
sensit
meropenem
amikacin
tazocin
suspend
meropenem
combin
amikacin
start
sputum
cultur
grew
acinetobact
spp
mdro
sensit
colistin
patient
screen
mer
cov
neg
still
symptomat
infect
control
team
recommend
continu
airborn
contact
isol
patient
condit
becam
wors
aspir
pneumonia
post
seizur
attack
also
develop
new
infiltr
cxr
requir
inotrop
support
start
colistin
vancomycin
caspofungen
continu
meropenem
amikacin
patient
becam
critic
condit
refractori
septic
shock
spite
good
coverag
mani
broad
spectrum
antibiot
deterior
rapidli
die
novemb
gene
expert
analysi
reveal
k
pneumonia
isol
blood
cultur
carbapenemas
produc
year
old
femal
known
type
diabet
mellitu
insulin
year
came
emerg
depart
case
infect
right
diabet
foot
sepsi
march
renal
impair
secondari
diabet
nephropathi
histori
icu
admiss
left
big
toe
amput
two
month
prior
present
admiss
bp
mm
hg
found
abnorm
renal
paramet
urea
creatinin
k
sodium
na
calcium
ca
laboratori
investig
show
glucos
hb
mcv
wbc
cellsmm
initi
clinic
evalu
clinic
condit
requir
immedi
transfer
oper
room
knee
amput
start
empir
tazocin
blood
cultur
show
c
glabrata
enterococcu
faecali
sensit
ampicillin
start
caspofungen
vancomycin
three
day
develop
right
leg
gangren
site
amput
debrid
done
tissu
specimen
sent
cultur
wound
cultur
right
foot
ulcer
tissu
specimen
infect
amput
site
show
heavi
growth
esbl
produc
k
pneumonia
resist
carbapenem
heavi
growth
e
faecali
start
ampicillin
gentamicin
infect
control
recommend
place
patient
contact
isol
forti
day
admiss
surgic
intens
care
sicu
patient
condit
improv
discharg
home
femal
admit
one
week
histori
fever
chill
diarrhea
abdomin
pain
gave
histori
renal
transplant
year
ago
cycloserin
steroid
admiss
bp
mm
hg
puls
rr
temperatur
c
serum
creatinin
patient
start
empir
tazocin
blood
cultur
grew
esbl
produc
k
pneumonia
resist
antibiot
except
colistin
blood
cultur
sensit
test
result
patient
start
intraven
colistin
million
unit
load
dose
follow
million
unit
everi
h
along
meropenem
g
everi
h
day
show
improv
discharg
good
condit
yearold
male
known
hypertens
invas
rectosigmoid
adenocarcinoma
perfor
recurr
intraabdomin
left
iliopsoa
abscess
chronic
kidney
diseas
histori
renal
stone
hydronephrosi
underw
divert
transvers
loop
colostomi
percutan
pig
tail
drainag
abscess
collect
one
month
prior
present
patient
admit
elect
chemotherapi
admiss
complain
left
loin
pain
radiat
groin
area
left
thigh
swell
notic
abdomin
ct
scan
show
improv
regard
size
appear
rectosigmoid
mass
reaccumul
abdomin
wall
left
pelvic
caviti
collect
abscess
diagnosi
left
psoa
abscess
pelvic
abdomin
wall
collect
recent
distant
metastasi
abdomen
chest
seen
abscess
collect
drain
sent
microbiolog
laboratori
left
pigtail
insert
patient
start
empir
imipenem
cultur
abscess
grew
e
coli
esbl
carbapenemas
produc
intermedi
imipenem
sensit
tigecyclin
base
sensit
result
recommend
infecti
team
meropenam
discontinu
tigecyclin
start
mg
hr
seven
day
treatment
ctabdomen
contrast
show
signific
regress
size
left
psoa
abscess
residu
measur
drainabl
collect
tigecyclin
continu
day
durat
antibiot
depend
complet
resolut
collect
base
clinic
laboratori
radiolog
find
becam
stabl
complic
complain
repeat
ct
scan
abdomen
pelvi
reveal
complet
resolut
psoa
abscess
patient
clinic
condit
improv
discharg
given
week
appoint
ct
abdomen
pelvi
assess
possibl
recollect
abscess
metastasi
year
old
femal
known
uncontrol
dm
type
ii
vascular
dementia
right
distal
femor
fractur
bedridden
bedsor
admit
august
uti
infect
grade
sacral
bedsor
complic
osteomyel
famili
note
lack
sleep
discomfort
physic
examin
show
infect
bed
sore
bilater
lung
crepit
tender
abdomen
vital
measur
reveal
c
axillari
rr
bp
spo
ngt
feed
foley
cathet
blood
cultur
grew
k
pneumonia
esbl
produc
wound
cultur
bedsor
grew
e
coli
esbl
produc
morganella
morganii
start
imipenem
mg
hourli
piperacillintazobactam
g
iv
total
week
seen
plastic
surgeon
debrid
clean
sacral
sore
use
povidon
soak
dress
flamazin
twice
daili
blood
sugar
adjust
regular
insulin
slide
scale
regular
insulin
unitsml
subcutan
inj
admiss
hematuria
foley
cathet
wash
done
weekend
patient
condit
deterior
arrest
admit
icu
resuscit
success
infecti
diseas
team
suggest
continu
meropenem
week
patient
complet
week
imipenem
seven
day
piperacillintazobactam
along
dress
infect
bed
sore
show
clinic
improv
look
sick
afebril
satur
chest
examin
show
reduc
air
bilater
complet
blood
count
show
leukocytosi
cxr
show
aspir
pneumonia
overal
respons
poor
repeat
cultur
bedsor
grew
e
aerogen
resist
carpapenem
infecti
diseas
impress
patient
chronic
osteomyel
recommend
repeat
esr
crp
mri
bone
assess
comorbid
prior
hospit
stay
surgic
procedur
observ
within
cohort
consist
previous
describ
risk
factor
identifi
retrospect
studi
cre
infect
sporad
outbreak
exposur
health
care
system
carbapenem
identifi
major
risk
factor
cre
acquisit
infect
studi
invas
infect
due
carbapenemresist
k
pneumonia
crkp
compar
carbapenemsuscept
k
pneumonia
found
associ
mechan
ventil
exposur
antimicrobi
longer
length
stay
recent
organ
transplant
admiss
intens
care
unit
also
associ
acquisit
crkp
carbapenem
frequent
use
treat
sever
infect
caus
multiresist
ampcor
extendedspectrum
esbl
produc
enterobacteriacea
unfortun
carbapenemresist
enterobacteriacea
report
mani
countri
carbapenemas
porin
loss
combin
ampc
enzym
hyperproduct
main
two
mechan
resist
carbapenem
resist
mediat
product
acquir
mbl
vim
imp
nonmetallocarbapenemas
iminmc
sme
oxa
kpc
famili
alter
loss
porin
member
enterobacteriacea
also
report
result
larg
hospitalbas
surveil
studi
china
genotyp
character
isol
enterobacteriacea
decreas
suscept
carbapenem
shown
moderateto
highlevel
carbapenem
resist
mainli
due
loss
decreas
express
major
porin
combin
product
ampc
esbl
enzym
carbapenemas
associ
low
moder
level
carbapenem
resist
hand
review
clinic
klebsiella
enterobact
spp
isol
uk
refer
laboratori
found
true
carbapenemas
product
combin
imperm
although
case
seri
molecular
analysi
perform
isol
carbapenemas
gene
blandm
type
seem
predomin
find
similar
previou
report
saudi
arabia
gulf
region
report
zowawi
et
al
investig
molecular
epidemiolog
mechan
resist
cre
obtain
countri
gulf
region
includ
saudi
arabia
common
carbapenemas
ndm
type
kpctype
vimtyp
imptyp
produc
detect
fact
first
two
clinic
case
carbapenemaseproduc
enterobacteriacea
unit
state
isol
patient
recent
hospit
saudi
arabia
india
enterobacteriacea
caus
hospit
commun
infect
increas
chanc
spread
cre
commun
hospit
patient
import
identifi
cre
infect
organ
transmit
hospit
health
care
facil
effect
infect
control
polici
includ
implement
notif
system
infectionprevent
measur
cre
identifi
laboratori
highli
recommend
identifi
cre
infect
colon
patient
place
contact
precaut
surveil
cultur
patient
epidemiolog
link
cre
casepati
consid
identifi
addit
unrecogn
cre
colon
patient
earli
detect
colon
case
allow
appropri
implement
contact
precaut
prevent
transmiss
patient
staff
activ
surveil
cultur
use
part
effect
polici
interrupt
transmiss
kpcproduc
k
pneumonia
sever
investig
remain
antibiot
current
use
treat
cre
infect
includ
polymyxin
tigecyclin
aminoglycosid
fosfomycin
temocillin
combin
therapi
drug
superior
monotherapi
associ
better
surviv
rate
seri
four
patient
die
due
septic
shock
refractori
treatment
combin
ceftazidimeavibactam
approv
food
drug
administr
fda
treat
complic
urinari
tract
complic
intraabdomin
infect
caus
cre
isol
produc
kpc
ampc
partial
activ
oxa
enzym
howev
drug
activ
ndm
vim
imp
although
patient
sever
underli
diseas
lack
delay
initi
appropri
treatment
might
contribut
poor
outcom
limit
case
seri
includ
lack
data
relat
prior
patent
stay
hospit
difficulti
follow
patient
discharg
final
outcom
relianc
physician
note
distinguish
infect
colon
identif
crkp
urin
alway
associ
urinari
tract
infect
case
seri
carbapenemresist
k
pneumonia
bacteriuria
crkp
bacteriuria
elect
admiss
endoscopi
probabl
repres
colon
rather
real
infect
qureshi
za
et
al
found
major
patient
crkp
identifi
urin
asymptomat
bacteriuria
rather
uti
molecular
diagnosi
perform
actual
resist
mechan
identifi
isol
conclus
cre
infect
grow
problem
hospit
expect
increas
preval
involv
hospit
believ
antibiot
stewardship
strict
infect
control
measur
essenti
prevent
spread
cre
purpos
control
spread
cre
institut
recommend
consid
activ
surveil
cultur
screen
patient
transfer
hospit
come
highli
endem
set
admiss
organ
final
research
need
institut
world
identifi
epidemiolog
molecular
profil
involv
cre
associ
infect
fund
sourc
